Evidence map›Paper›PMID 30728747›Full record

ArticleMediators of inflammation2019

Mannan-Binding Lectin Suppresses Peptidoglycan-Induced TLR2 Activation and Inflammatory Responses.

Fanping Wang, Yanhua Li, Can Yang, Yonghui Mu, Yan Wang, Wei Zhang, Yonghui Yang, Chen Chen, Shijun Song, Zhifa Shen and 7 more

Open access · goldAbstract read
In one paragraph

Article in Mediators of inflammation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

  1. Frontiers in microbiology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Fanping WangSchool of Laboratory Medicine, Xinxiang Medical University, Xinxiang 453003, China.
Yanhua LiCollaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine, Xinxiang 453003, China.
Can YangCollaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine, Xinxiang 453003, China.
Yonghui MuSchool of Basic Medical Sciences, Xinxiang Medical University, Xinxiang 453003, China.
Yan WangSchool of Laboratory Medicine, Xinxiang Medical University, Xinxiang 453003, China.
Wei ZhangSchool of Basic Medical Sciences, Xinxiang Medical University, Xinxiang 453003, China.
Yonghui YangSchool of Laboratory Medicine, Xinxiang Medical University, Xinxiang 453003, China.
Chen ChenDepartment of Clinical Laboratory, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, China.
Shijun SongDepartment of Clinical Laboratory, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, China.
Zhifa ShenSchool of Laboratory Medicine, Xinxiang Medical University, Xinxiang 453003, China.
Wenjun WangState Key Laboratory of Respiratory Diseases, Center for Translational Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.
Junpeng LiDepartment of Clinical Laboratory, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, China.
Jingjing ZhaiDepartment of Laboratory Medicine, Women and Infants Hospital of Zhengzhou, Zhengzhou 450012, China.
Kang GuoDepartment of Clinical Laboratory, The Third Affiliated Hospital of Xinxiang Medical University, Xinxiang, China.
Ruili SunSchool of Laboratory Medicine, Xinxiang Medical University, Xinxiang 453003, China.
Lili YuCollaborative Innovation Center of Molecular Diagnosis and Laboratory Medicine, Xinxiang 453003, China.ORCID 0000-0001-5832-1024
Mingyong WangSchool of Laboratory Medicine, Xinxiang Medical University, Xinxiang 453003, China.ORCID 0000-0003-1057-2603
Xinxiang Medical University · CNFirst Affiliated Hospital of Guangzhou Medical University · CNZhengzhou City Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peptidoglycan (PGN), as the major components of the bacterial cell wall, is known to cause excessive proinflammatory cytokine production. Toll-like receptor 2 (TLR2) is abundantly expressed on immune cells and has been shown to be involved in PGN-induced signaling. Although more and more evidences have indicated that PGN is recognized by TLR2, the role of TLR2 PGN recognition is controversial. Mannan-binding lectin (MBL), a plasma C-type lectin, plays a key role in innate immunity. More and more evidences show that MBL could suppress the amplification of inflammatory signals. Whether MBL can alter PGN-elicited cellular responses through TLR2 in macrophages is still unknown, and possible mechanism underlying it should be investigated. In this study, we found that MBL significantly attenuated PGN-induced inflammatory cytokine production, including TNF-

Indexed as

Active Transport, Cell NucleusCytokinesGene Expression RegulationHumansInflammationInterleukin-6MacrophagesMannose-Binding LectinNF-kappa B p50 Subunitp38 Mitogen-Activated Protein KinasesPeptidoglycanPhosphorylationSaccharomyces cerevisiaeSignal TransductionTHP-1 CellsToll-Like Receptor 2CytokinesIL6 protein, humanInterleukin-6Mannose-Binding LectinNF-kappa B p50 SubunitNFKB1 protein, humanp38 Mitogen-Activated Protein KinasesPeptidoglycanTLR2 protein, humanToll-Like Receptor 2Tumor Necrosis Factor-alpha

Identifiers

PMID30728747
PMCPMC6343158
OpenAlexW2909795666

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.